1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Peritoneal cancer

Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis

Interventional procedures guidance [IPG681] Published: 28 October 2020

Register an interest
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendation(s) from an individual piece of guidance

Guidance:
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis
Date issued:
28 October 2020

Research recommendations coming out of this guidance

  • Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis shows that this procedure can cause serious but well-recognised side effects. Evidence on its efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website.